Programme (Day 2: 8 Nov)

Download Programme

08:30 – 09:00	Opening Ceremony
09:00 – 10:00	Keynote Lecture Moderators: Joo-young Kim and Wing-hong Kwan
	Future Perspective in Particle Therapy Marco Durante Director Biophysics Department GSI Helmholtz Centre for Heavy Ion Research Germany Prof. Dr. Marco Durante is Director of the Biophysics Department at GSI Helmholtz Center for Heavy Ion Research (Darmstadt, Germany), and Full Professor of Physics at the Technical University of Darmstadt and at the University of Naples Federico II in Italy. Dr. Durante got his Ph.D. in physics in 1992 and has worked as postdoc at the NASA Lyndon B. Johnson Space Center (Houston, TX, USA) and NIRS-QST (Chiba, Japan). He is generally recognized as world leader in the field of particle radiobiology and medical physics and is co-author of over 530 papers in peer-reviewed scientific journals (h-index=67). He is currently chair of the Particle Therapy Co-Operative Group (PTCOG). His main scientific achievement has been the assessment of the biological effects of accelerated charged particles using both in vitro systems and samples from humans (astronauts and cancer patients). Marco Durante (Germany)
	The JASTRO Initiative on National Registry and Insurance Coverage Expansion in Particle Therapy Tatsuya Ohno Chair and Director Department of Radiation Oncology Gunma University Heavy Ion Medical Center Japan Dr. Ohno is a radiation oncologist, Professor and Chair of Department of Radiation Oncology of Gunma University, and Director of Gunma University Heavy Ion Medical Center, Japan. He is also Chair of the Asia-Oceania Particle Therapy Cooperative Group (PTCOG-AO). He is a core member of the particle therapy community in Japan, and active member of the Japan Carbon-ion Radiation Oncology Study Group (J-CROS). He has served as a Course Director on International Training Course on Carbon-ion Radiotherapy (ITCCIR) co-hosted by QST hospital and Gunma University since 2012. He has published more than 250 papers on clinical and basic research and has collaborated many overseas particle therapy projects. Tatsuya Ohno (Japan)
10:00 – 10:30	Coffee Break, Exhibition and e-Poster Viewing Mini Oral Presentations 3A (Clinical / Biology) Judges of Mini Oral Presentations: Amy Chang Co-director HKSH Proton Therapy Centre Hong Kong Sanatorium & Hospital Hong Kong Dr. Chang is currently Honorary Consultant in Clinical Oncology at Hong Kong Sanatorium & Hospital, co-director of HKSH Proton Therapy Centre, Honorary Clinical Associate Professor (CUHK) and Honorary Clinical Assistant Professor of the Department of Clinical Oncology, The University of Hong Kong. She obtained Bachelor of Science in Biological Chemistry at University of Chicago and obtained her medical degree from The University of Hong Kong in 2002. After internship she was trained in Department of Clinical Oncology of Pamela Youde Nethersole Eastern Hospital. She is a fellow of the Royal College of Radiologists and Hong Kong College of Radiologists (2012) and worked as Clinical Assistant Professor at University of Hong Kong Department of Clinical Oncology. During her service at the Hospital Authority and as an academic staff, she obtained the Hong Kong College of Radiologists Fellowship Grant to study advanced radiotherapy technique in Cambridge University, and was also trained at Medical University of Vienna. She pioneered in MR-guided brachytherapy for cervix cancer in her institute, organized training workshops, and also led a multi-center research study as the principal applicant of the Government Health and Medical Research Fund (HMRF) on the clinical outcome of this advanced technology for cervix cancer patients. She joined Hong Kong Sanatorium & Hospital since 2019 and continued her aspiration in the implementation of innovative radiotherapy techniques and research works. She is dedicated in the set up and development of the Proton Therapy Service in the Hospital, the first in Hong Kong, the most cutting edge therapy that shows significant reduction of side effects of radiotherapy treatment compared to traditional X-ray based radiotherapy. She and the HKSH team developed a training program with Mayo Clinic Arizona, USA, with ongoing efforts aiming to train all related staffs for safe practice of the new technique. She is recognized as a council member in various international radiotherapy groups such as the steering committee member for the Proton Particle Therapy Co-operative group (PTCOG), international committee council member of the American Brachytherapy Society, European Brachytherapy Group (GEC-ESTRO), and locally, honorary teaching positions in both HKU, CUHK and HKU-Shenzhen Hospital, with continue academic collaborations with various universities including HK Polytechnique University. Amy Chang and Tae-hyun Kim Mini Oral Presentation 3B (Physics) Judges of Mini Oral Presentations: Dongho Shin and Toshiyuki Toshito
10:30 – 12:30	Session 5A (Physics): Imaging in Proton Therapy Moderators: Taku Inaniwa and Louis Lee
	Imaging in Proton Therapy Chia-ho Hua Director of Medical Physics Research Department of Radiation Oncology St. Jude Children's Research Hospital USA Dr. Chia-ho Hua earned his PhD in Biomedical Engineering from The University of Michigan in Ann Arbor, where he studied radionuclide tomographic imaging. He received postdoctoral and clinical training in therapeutic medical physics at Memorial Sloan-Kettering Cancer Center in New York. He was certified by the American Board of Radiology in Therapeutic Medical Physics in 2004. Dr. Hua joined the faculty at St. Jude in 2005 and is currently a Full Member and the Director of Medical Physics Research. His research aims to improve proton therapy targeting accuracy, advanced imaging for precision radiation oncology, and predictive modeling for radiation effects in children. Dr. Hua is also the Physics Committee Chair of the Children's Oncology Group Radiation Oncology Discipline and the steering committee member of the Pediatric Normal Tissue Effects in the Clinic (PENTEC) international consortium. In 2023, Dr. Hua was elected as a Fellow of the American Association of Physicists in Medicine (FAAPM). Chia-ho Hua (USA)
	Role of CT Image Guidance for Proton Radiotherapy and Related Researches Aiming for High Precision Treatment Yoshikazu Maeda Professor Division of Human and Artificial Intelligent Systems Graduate School of Engineering University of Fukui Japan Dr Yoshikazu Maeda is a Professor in Division of Human and Artificial Intelligent Systems　Graduate School of Engineering, University of Fukui, Japan (2025-preset). He graduated from Osaka University in 2000 with a Ph.D. in Experimental Nuclear Physics. He was a Research Scientist in Nuclear Physics Institute, Research Center Juelich GMBL, Germany (2001-2006), and in Research Center for Nuclear Physics, Osaka University (2000-2001,2006-2009). He was a senior researcher and medical physicist in Fukui Prefectural hospital proton therapy center (2009-2025). He was engaged in the construction of a proton therapy facility (2009-2011) and realized the safe operation of the facility. His main research interests include the proton dose calculation using the Monte Carlo method and the study of CT image-guided proton therapy, where the efficacy of CT image guidance in prostate cancer and liver cancer and the importance of online proton dose monitoring. A support technology based on AI technology for lesion recognition in CT image is now main topics. Yoshikazu Maeda (Japan)
	AI-based Real-time Tumor Tracking Proton Therapy Toshiyuki Terunuma Assistant Professor / Medical Physicist Proton Medical Research Center University of Tsukuba Japan Dr. Toshiyuki Terunuma is an assistant professor in both the Institute of Medicine and the Proton Medical Research Center at the University of Tsukuba, specializing in medical physics and radiation science. He earned a Bachelor of Engineering from Utsunomiya University, followed by a Master's degree in Applied Physics and a Ph.D. in Medicine from the University of Tsukuba. He has extensive experience with hardware and software systems in proton therapy, including accelerator operation, dosimetry, treatment planning, and image-guidance software development. His current research focuses on image-guided radiotherapy, particularly in real-time markerless tumor tracking using attention-based augmentation and patient-specific deep learning models. He is also working on ionoacoustic imaging for proton beam verification Toshiyuki Terunuma (Japan)
	MRI-guidance in Proton Therapy Leon Ho Medical Physicist I Medical Physics Department HKSH Eastern Medical Centre Hong Kong Dr. Leon Chin Chak HO received his B.Eng. and Ph.D. degrees from The University of Hong Kong (HKU) in 2011 and 2016, respectively. Following his doctoral studies, he joined Hong Kong Sanatorium & Hospital (HKSH) Medical Group as a medical physicist. After receiving his board-certification in radiation oncology physics from the Hong Kong Institution of Physicists in Medicine (HKIPM), Dr. Ho was appointed as an honorary assistant professor by the Department of Diagnostic Radiology at The University of Hong Kong. His research interests include MR-guidance in radiation therapy, as well as the development of MR-integrated workflows in radiotherapy and proton therapy. Leon Ho (Hong Kong, China)
12:30 – 14:00	Lunch Break
14:00 – 15:40	Session 6A (Physics): Oral Presentation Moderators: Chia-ho Hua Director of Medical Physics Research Department of Radiation Oncology St. Jude Children's Research Hospital USA Dr. Chia-ho Hua earned his PhD in Biomedical Engineering from The University of Michigan in Ann Arbor, where he studied radionuclide tomographic imaging. He received postdoctoral and clinical training in therapeutic medical physics at Memorial Sloan-Kettering Cancer Center in New York. He was certified by the American Board of Radiology in Therapeutic Medical Physics in 2004. Dr. Hua joined the faculty at St. Jude in 2005 and is currently a Full Member and the Director of Medical Physics Research. His research aims to improve proton therapy targeting accuracy, advanced imaging for precision radiation oncology, and predictive modeling for radiation effects in children. Dr. Hua is also the Physics Committee Chair of the Children's Oncology Group Radiation Oncology Discipline and the steering committee member of the Pediatric Normal Tissue Effects in the Clinic (PENTEC) international consortium. In 2023, Dr. Hua was elected as a Fellow of the American Association of Physicists in Medicine (FAAPM). Chia-ho Hua and Tony Wong Judges: Hong-qi Tan Deputy Head of Medical Physics Division of Radiation Oncology National Cancer Centre Singapore Tan Hong Qi is currently the deputy head of medical physics in joined National Cancer Centre Singapore (NCCS) overseeing clinical and research project. He holds an adjunct assistant professor position in Nanyang Technological University and developed the first medical physics bachelor program in Singapore. He is a diplomate of International Medical Physics Certification Board (IMPCB) and is also a clinical instructor in the Duke-NUS medical school as well. He has received multiple awards at the institutional, national and international level. This includes the SingHealth AHP young discoverer award in 2021, represented Singapore as an invited expert to IAEA technical meeting on radiation protection of paediatric and pregnant patients in 2023, SEAFOMP Young Leader award in 2023 and the IUPAP early career scientist award in 2023, innovative practice team awards in 2024 and 2025. Hong-qi Tan and Dayananda Sharma Professor and Head Department of Medical Physics Apollo Proton Cancer Centre India Dayananda Sharma
15:40 – 16:00	Coffee Break, Exhibition and e-Poster Viewing Mini Oral Presentations 4A (Clinical / Biology) Judges of Mini Oral Presentations: Amy Chang Co-director HKSH Proton Therapy Centre Hong Kong Sanatorium & Hospital Hong Kong Dr. Chang is currently Honorary Consultant in Clinical Oncology at Hong Kong Sanatorium & Hospital, co-director of HKSH Proton Therapy Centre, Honorary Clinical Associate Professor (CUHK) and Honorary Clinical Assistant Professor of the Department of Clinical Oncology, The University of Hong Kong. She obtained Bachelor of Science in Biological Chemistry at University of Chicago and obtained her medical degree from The University of Hong Kong in 2002. After internship she was trained in Department of Clinical Oncology of Pamela Youde Nethersole Eastern Hospital. She is a fellow of the Royal College of Radiologists and Hong Kong College of Radiologists (2012) and worked as Clinical Assistant Professor at University of Hong Kong Department of Clinical Oncology. During her service at the Hospital Authority and as an academic staff, she obtained the Hong Kong College of Radiologists Fellowship Grant to study advanced radiotherapy technique in Cambridge University, and was also trained at Medical University of Vienna. She pioneered in MR-guided brachytherapy for cervix cancer in her institute, organized training workshops, and also led a multi-center research study as the principal applicant of the Government Health and Medical Research Fund (HMRF) on the clinical outcome of this advanced technology for cervix cancer patients. She joined Hong Kong Sanatorium & Hospital since 2019 and continued her aspiration in the implementation of innovative radiotherapy techniques and research works. She is dedicated in the set up and development of the Proton Therapy Service in the Hospital, the first in Hong Kong, the most cutting edge therapy that shows significant reduction of side effects of radiotherapy treatment compared to traditional X-ray based radiotherapy. She and the HKSH team developed a training program with Mayo Clinic Arizona, USA, with ongoing efforts aiming to train all related staffs for safe practice of the new technique. She is recognized as a council member in various international radiotherapy groups such as the steering committee member for the Proton Particle Therapy Co-operative group (PTCOG), international committee council member of the American Brachytherapy Society, European Brachytherapy Group (GEC-ESTRO), and locally, honorary teaching positions in both HKU, CUHK and HKU-Shenzhen Hospital, with continue academic collaborations with various universities including HK Polytechnique University. Amy Chang and Tae-hyun Kim Mini Oral Presentation 4B (Physics) Judges of Mini Oral Presentations: Dongho Shin and Toshiyuki Toshito
16:00 – 18:00	Session 7A (Physics): High Precision Proton Therapy Moderators: John Wong and Jing Cai
	Development of a Pencil Beam Scanning Based Stereotactic Radiosurgery Program at Mayo Clinic in Arizona Martin Bues Lead Proton Physicist and Professor of Radiation Oncology Department of Radiation Oncology Mayo Clinic USA Martin Bues (USA)
	Treatment of Small Target in Proton Therapy Chen-yu Chou Senior Medical Physicist Department of Radiation Oncology Chang Gang Memorial Hospital, Linkou branch Taiwan Chen-Yu Chou is a highly skilled medical physicist with over a decade of experience in radiation therapy. He holds an M.S. in Medical Technology and Engineering and is currently pursuing a doctoral degree. Certified as a radiotherapist, radiation protection specialist, and medical physicist, Chou has been a key member of Linkou Chang Gung Memorial Hospital since 2014. He leads quality assurance for a wide range of radiotherapy systems, including linear accelerators, proton systems, brachytherapy, and CT. Chou specializes in developing advanced treatment plans for various cancer types, including photon and proton therapy, and plays a key role in the proton stereotactic radiosurgery program. His research interests include planning optimization, MRI simulation, and proton therapy, resulting in numerous publications and presentations. An invited speaker at conferences, Chou has held leadership roles as Supervisor of the Society of Medical Physics and served as an Oral Examiner for the Medical Physicist License Examination in Taiwan. Chen-yu Chou (Taiwan)
	Adaptive Proton Therapy Dayananda Sharma Professor and Head Department of Medical Physics Apollo Proton Cancer Centre India Dayananda Sharma (India)
	Biology and Clinical Relevance of FLASH Radiotherapy G-One Ahn Associate Professor College of Veterinary Medicine Seoul National University Republic of Korea G-one Ahn (Korea)
18:00 – 18:15	Closing Remarks and Award Ceremony for Oral / Mini Oral Presentation

10:30 – 11:00	Session 5B (Clinical): Updates on Clinical Management Moderators: Kyung-hwan Kim and Rico Liu
	The Role of Proton Beam Radiotherapy in Non-Small Cell Lung Cancer: Lessons Learned and the Path Forward Ramesh Rengan Peter Wootton Professor and Chair Department of Radiation Oncology, UW Medicine SVP, Fred Hutchinson Cancer Center USA Dr. Ramesh Rengan is currently the Peter Wootton Chair and Professor in the Department of Radiation Oncology at the University of Washington School of Medicine and the Senior Vice President and Director in Radiation Oncology Division at the Fred Hutchinson Cancer Center. He also holds a joint appointment as faculty of the Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center. His clinical interests include thoracic malignancies, melanomas (including ocular melanoma), renal cell carcinoma, and prostate cancer. Additionally, he has clinical expertise in the use of proton beam therapy in the management of localized and locally advanced solid tumors. His research interests include approaches to improve the therapeutic ratio in solid tumors to ionizing photon or proton radiation, pre-clinical and clinical strategies to utilize radiation to trigger an anti-tumor immune response in patients with advanced solid malignancies. He also has an interest in healthcare disparities and expanded access to radiation treatment in low-resource environments and Photon- and Proton based radiation regimens to trigger an immune response to augment immunotherapeutic platforms in solid malignancies including NSCLC, melanoma, lymphoma, and renal cell carcinoma. Ramesh Rengan (USA)
11:00 – 12:40	Session 6B (Clinical / Biology): Oral Presentation Moderators: Amy Chang Co-director HKSH Proton Therapy Centre Hong Kong Sanatorium & Hospital Hong Kong Dr. Chang is currently Honorary Consultant in Clinical Oncology at Hong Kong Sanatorium & Hospital, co-director of HKSH Proton Therapy Centre, Honorary Clinical Associate Professor (CUHK) and Honorary Clinical Assistant Professor of the Department of Clinical Oncology, The University of Hong Kong. She obtained Bachelor of Science in Biological Chemistry at University of Chicago and obtained her medical degree from The University of Hong Kong in 2002. After internship she was trained in Department of Clinical Oncology of Pamela Youde Nethersole Eastern Hospital. She is a fellow of the Royal College of Radiologists and Hong Kong College of Radiologists (2012) and worked as Clinical Assistant Professor at University of Hong Kong Department of Clinical Oncology. During her service at the Hospital Authority and as an academic staff, she obtained the Hong Kong College of Radiologists Fellowship Grant to study advanced radiotherapy technique in Cambridge University, and was also trained at Medical University of Vienna. She pioneered in MR-guided brachytherapy for cervix cancer in her institute, organized training workshops, and also led a multi-center research study as the principal applicant of the Government Health and Medical Research Fund (HMRF) on the clinical outcome of this advanced technology for cervix cancer patients. She joined Hong Kong Sanatorium & Hospital since 2019 and continued her aspiration in the implementation of innovative radiotherapy techniques and research works. She is dedicated in the set up and development of the Proton Therapy Service in the Hospital, the first in Hong Kong, the most cutting edge therapy that shows significant reduction of side effects of radiotherapy treatment compared to traditional X-ray based radiotherapy. She and the HKSH team developed a training program with Mayo Clinic Arizona, USA, with ongoing efforts aiming to train all related staffs for safe practice of the new technique. She is recognized as a council member in various international radiotherapy groups such as the steering committee member for the Proton Particle Therapy Co-operative group (PTCOG), international committee council member of the American Brachytherapy Society, European Brachytherapy Group (GEC-ESTRO), and locally, honorary teaching positions in both HKU, CUHK and HKU-Shenzhen Hospital, with continue academic collaborations with various universities including HK Polytechnique University. Amy Chang and Shigeru Yamada Judges: Yu-Ming Wang and Ru-xin Wong
12:40 – 14:00	Lunch Symposium 2 Moderator: Amy Chang Co-director HKSH Proton Therapy Centre Hong Kong Sanatorium & Hospital Hong Kong Dr. Chang is currently Honorary Consultant in Clinical Oncology at Hong Kong Sanatorium & Hospital, co-director of HKSH Proton Therapy Centre, Honorary Clinical Associate Professor (CUHK) and Honorary Clinical Assistant Professor of the Department of Clinical Oncology, The University of Hong Kong. She obtained Bachelor of Science in Biological Chemistry at University of Chicago and obtained her medical degree from The University of Hong Kong in 2002. After internship she was trained in Department of Clinical Oncology of Pamela Youde Nethersole Eastern Hospital. She is a fellow of the Royal College of Radiologists and Hong Kong College of Radiologists (2012) and worked as Clinical Assistant Professor at University of Hong Kong Department of Clinical Oncology. During her service at the Hospital Authority and as an academic staff, she obtained the Hong Kong College of Radiologists Fellowship Grant to study advanced radiotherapy technique in Cambridge University, and was also trained at Medical University of Vienna. She pioneered in MR-guided brachytherapy for cervix cancer in her institute, organized training workshops, and also led a multi-center research study as the principal applicant of the Government Health and Medical Research Fund (HMRF) on the clinical outcome of this advanced technology for cervix cancer patients. She joined Hong Kong Sanatorium & Hospital since 2019 and continued her aspiration in the implementation of innovative radiotherapy techniques and research works. She is dedicated in the set up and development of the Proton Therapy Service in the Hospital, the first in Hong Kong, the most cutting edge therapy that shows significant reduction of side effects of radiotherapy treatment compared to traditional X-ray based radiotherapy. She and the HKSH team developed a training program with Mayo Clinic Arizona, USA, with ongoing efforts aiming to train all related staffs for safe practice of the new technique. She is recognized as a council member in various international radiotherapy groups such as the steering committee member for the Proton Particle Therapy Co-operative group (PTCOG), international committee council member of the American Brachytherapy Society, European Brachytherapy Group (GEC-ESTRO), and locally, honorary teaching positions in both HKU, CUHK and HKU-Shenzhen Hospital, with continue academic collaborations with various universities including HK Polytechnique University. Amy Chang
	Proton Therapy / SRS Applications in Brain Tumors Sujay Vora Professor and Chair Department of Radiation Oncology Mayo Clinic College of Medicine USA Sujay A. Vora, M.D., is chair and a consultant in the Department of Radiation Oncology at Mayo Clinic in Arizona, with a joint appointment in the Department of Neurologic Surgery. He joined the staff of Mayo Clinic in 2000 and holds the academic rank of professor of radiation oncology, Mayo Clinic College of Medicine and Science. Dr. Vora earned his B.A. in biomedical engineering at Johns Hopkins University in Baltimore and his M.D. at the University of Pittsburgh. Dr. Vora's clinical and research interests focus on neuro-oncology. He has been involved with multiple trials and has initiated several clinical programs. His most significant work utilized a novel approach of advanced medical imaging with short-course proton beam therapy to treat elderly patients with glioblastoma. This hallmark study demonstrating improved survival and quality of life was published in November 2024 Lancet Oncology. This treatment regimen is now being compared to standard-of-care radiation for all patients with glioblastoma. Sujay Vora (USA)
	Case Discussions & Q&A Panelists: Amy Chang Co-director HKSH Proton Therapy Centre Hong Kong Sanatorium & Hospital Hong Kong Dr. Chang is currently Honorary Consultant in Clinical Oncology at Hong Kong Sanatorium & Hospital, co-director of HKSH Proton Therapy Centre, Honorary Clinical Associate Professor (CUHK) and Honorary Clinical Assistant Professor of the Department of Clinical Oncology, The University of Hong Kong. She obtained Bachelor of Science in Biological Chemistry at University of Chicago and obtained her medical degree from The University of Hong Kong in 2002. After internship she was trained in Department of Clinical Oncology of Pamela Youde Nethersole Eastern Hospital. She is a fellow of the Royal College of Radiologists and Hong Kong College of Radiologists (2012) and worked as Clinical Assistant Professor at University of Hong Kong Department of Clinical Oncology. During her service at the Hospital Authority and as an academic staff, she obtained the Hong Kong College of Radiologists Fellowship Grant to study advanced radiotherapy technique in Cambridge University, and was also trained at Medical University of Vienna. She pioneered in MR-guided brachytherapy for cervix cancer in her institute, organized training workshops, and also led a multi-center research study as the principal applicant of the Government Health and Medical Research Fund (HMRF) on the clinical outcome of this advanced technology for cervix cancer patients. She joined Hong Kong Sanatorium & Hospital since 2019 and continued her aspiration in the implementation of innovative radiotherapy techniques and research works. She is dedicated in the set up and development of the Proton Therapy Service in the Hospital, the first in Hong Kong, the most cutting edge therapy that shows significant reduction of side effects of radiotherapy treatment compared to traditional X-ray based radiotherapy. She and the HKSH team developed a training program with Mayo Clinic Arizona, USA, with ongoing efforts aiming to train all related staffs for safe practice of the new technique. She is recognized as a council member in various international radiotherapy groups such as the steering committee member for the Proton Particle Therapy Co-operative group (PTCOG), international committee council member of the American Brachytherapy Society, European Brachytherapy Group (GEC-ESTRO), and locally, honorary teaching positions in both HKU, CUHK and HKU-Shenzhen Hospital, with continue academic collaborations with various universities including HK Polytechnique University. Amy Chang (Hong Kong), Chun-key Law Co-director of Proton therapy Centre Honorary Consultant in Clinical Oncology Comprehensive Oncology Centre, Department of Medicine Hong Kong Sanatorium & Hospital Hong Kong Dr. CK Law graduated from University of Hong Kong in 1981 and joined the Department of Radiotherapy & Oncology (now called Department of Clinical Oncology), Queen Elizabeth Hospital in 1982. He had post-Fellowship training in United Kingdom, Japan and the USA. He became Chief of Service in 2003 until retirement from the public service in 2012. He had been the Director of Hong Kong Cancer Registry, Hospital Authority in 2004 - 2012 and President of Hong Kong College of Radiologists in 2008 - 2023. Dr. Law is currently a member of the Cancer Expert Working Group (CEWG) of the Centre for Health Protection (CHP) as well as the Advisory Committee for Regulatory Standards for Private Healthcare Facilities, Department of Health. He is also an Honorary Clinical Associate Professor in Department of Clinical Oncology, The University of Hong Kong, and Clinical Associate Professor (Honorary), Department of Medicine and Therapeutics, The Chinese University of Hong Kong. He is currently serving in Hong Kong Sanatorium and Hospital as Honorary Consultant in Clinical Oncology and Co-director of Proton Therapy Centre in HKSH Eastern Medical Centre. Chun-key Law (Hong Kong), Kar-ming Leung Co-Director HKSH Neurosurgery Centre Hong Kong Sanatorium & Hospital Hong Kong Dr. Kar-ming Leung is the Co-Director and Honorary Consultant in Neurosurgery in Neurosurgery Centre, Hong Kong Sanatorium & Hospital. He is also serving as Honorary Clinical Associate Professor in the University of Hong Kong and trainer in the College of Surgeons of Hong Kong. He has special interest in treatment of cerebrovascular diseases, including cerebral aneurysms, arteriovenous malformations and brain tumours. He started his training in Hong Kong and obtained his Fellowships in the College of Surgeons of Edinburgh and the College of Surgeons of Hong Kong in mid-90's, followed by overseas training in UCLA Medical Centre and Barrow Neurological Institute in USA. He is currently council member of various societies including the Hong Kong Neurosurgical Society, the Hong Kong Stroke Society, the Hong Kong Specialist Medical Association, the Hong Kong Society of Interventional and Therapeutic Neuroradiology, and the Association of Private Medical Specialist of Hong Kong. Kar-ming Leung (Hong Kong), Sujay Vora Professor and Chair Department of Radiation Oncology Mayo Clinic College of Medicine USA Sujay A. Vora, M.D., is chair and a consultant in the Department of Radiation Oncology at Mayo Clinic in Arizona, with a joint appointment in the Department of Neurologic Surgery. He joined the staff of Mayo Clinic in 2000 and holds the academic rank of professor of radiation oncology, Mayo Clinic College of Medicine and Science. Dr. Vora earned his B.A. in biomedical engineering at Johns Hopkins University in Baltimore and his M.D. at the University of Pittsburgh. Dr. Vora's clinical and research interests focus on neuro-oncology. He has been involved with multiple trials and has initiated several clinical programs. His most significant work utilized a novel approach of advanced medical imaging with short-course proton beam therapy to treat elderly patients with glioblastoma. This hallmark study demonstrating improved survival and quality of life was published in November 2024 Lancet Oncology. This treatment regimen is now being compared to standard-of-care radiation for all patients with glioblastoma. Sujay Vora (USA)
14:00 – 15:30	Session 7B (Clinical): Updates on Clinical Management Moderators: Chi-leung Chiang and Terence Tai-weng Sio Professor of Radiation Oncology Department of Radiation Oncology Mayo Clinic Arizona, Phoenix, AZ USA Terence T. Sio, M.D., M.S., is Professor of Radiation Oncology and radiation oncologist who specializes in both X-ray based and proton radiotherapies. His main focuses are in gastrointestinal, lung, and brain cancers including brain metastasis treatments using stereotactic radiosurgery (SRS). He has a strong interest in ion beam radiotherapies internationally Terence Tai-weng Sio
	Experience and Evidence of Particle Beam Therapy for the Liver Tumor Hideyuki Sakurai Professor and Chairman Department of Radiation Oncology, University of Tsukuba Director Proton Beam Therapy Center, University of Tsukuba Hospital Japan Hideyuki Sakurai received the medical degree in Gunma University in 1988 and the PhD degree in 1996. In 1992, he served as visiting scientist in Medical Research Council at Cambridge University in UK. He is currently a professor and Chairman in Radiation Oncology, Institute of Medicine, University of Tsukuba. He is also Director in Proton Beam Therapy Center, University of Tsukuba Hospital. He has been holding leadership, supervisory and administrative positions in particle therapy research in Japanese Society of Radiation Oncology (JASTRO), because he has been chair of particle therapy committee in JASTRO. In addition, brachytherapy, hyperthermia and boron neutron capture therapy are also his special interest. He has published over 500 articles on the basic research, translational medicine and clinical trial in radiation oncology. Hideyuki Sakurai (Japan)
	Discussion Forum 1: Liver Cancer Topics: Motion Management, Hypofractionation, Multidisciplinary Care with Surgery and Systemic Therapy Moderators: Chi-leung Chiang and Terence Tai-weng Sio Professor of Radiation Oncology Department of Radiation Oncology Mayo Clinic Arizona, Phoenix, AZ USA Terence T. Sio, M.D., M.S., is Professor of Radiation Oncology and radiation oncologist who specializes in both X-ray based and proton radiotherapies. His main focuses are in gastrointestinal, lung, and brain cancers including brain metastasis treatments using stereotactic radiosurgery (SRS). He has a strong interest in ion beam radiotherapies internationally Terence Tai-weng Sio Panelists: Hsiao-chieh Huang Chief Medical Physicist Department of Radiation Oncology Chang Gang Memorial Hospital, Linkou branch Taiwan Hsiao-Chieh Huang is the Chief Medical Physicist at Chang Gung Memorial Hospital, Linkou. Since joining in 2004, he has been involved in the commissioning and acceptance testing of linear accelerators and proton therapy systems. He played a key role in establishing quality assurance (QA) protocols and operational guidelines at CGMH. During the early development of the proton center, he was responsible for beam data collection, treatment planning system (TPS) validation, and QA implementation. Currently, he leads the medical physics team, overseeing clinical services and research projects to improve treatment accuracy and efficiency. His expertise spans both proton and photon therapy, with a focus on optimizing QA methodologies and advancing proton therapy applications. Hsiao-chieh Huang (Taiwan), Thomas Leung Honorary Consultant in Medical Oncology Director of the Clinical Trial Centre Hong Kong Sanatorium and Hospital Hong Kong Dr. Leung is currently Honorary Consultant in Medical Oncology, Director of the Clinical Trial Centre, at the Hong Kong Sanatorium and Hospital. He is also Honorary Associate Professor of the Department of Medicine in the Chinese University of Hong Kong. He was previously Professor in the Department of Clinical Oncology of Chinese University of Hong Kong until 2003 when he assumed the current position. Dr. Leung has over 160 publications in peer-reviewed journals and 9 book chapters mainly on hepatocellular carcinoma (HCC), with a special focus on the management strategy in patients with advanced HCC and in the Asian population. Dr Leung also participated in various international consensus panels and gave recommendation on the use of systemic treatment, as well as the use Y-90 microspheres radioembolization. His research interests are non surgical treatment for advanced HCC. Thomas Leung (Hong Kong, China) and Hideyuki Sakurai (Japan)
15:40 – 16:00	Coffee Break, Exhibition and e-Poster Viewing Mini Oral Presentations 4A (Clinical / Biology) Judges of Mini Oral Presentations: Amy Chang Co-director HKSH Proton Therapy Centre Hong Kong Sanatorium & Hospital Hong Kong Dr. Chang is currently Honorary Consultant in Clinical Oncology at Hong Kong Sanatorium & Hospital, co-director of HKSH Proton Therapy Centre, Honorary Clinical Associate Professor (CUHK) and Honorary Clinical Assistant Professor of the Department of Clinical Oncology, The University of Hong Kong. She obtained Bachelor of Science in Biological Chemistry at University of Chicago and obtained her medical degree from The University of Hong Kong in 2002. After internship she was trained in Department of Clinical Oncology of Pamela Youde Nethersole Eastern Hospital. She is a fellow of the Royal College of Radiologists and Hong Kong College of Radiologists (2012) and worked as Clinical Assistant Professor at University of Hong Kong Department of Clinical Oncology. During her service at the Hospital Authority and as an academic staff, she obtained the Hong Kong College of Radiologists Fellowship Grant to study advanced radiotherapy technique in Cambridge University, and was also trained at Medical University of Vienna. She pioneered in MR-guided brachytherapy for cervix cancer in her institute, organized training workshops, and also led a multi-center research study as the principal applicant of the Government Health and Medical Research Fund (HMRF) on the clinical outcome of this advanced technology for cervix cancer patients. She joined Hong Kong Sanatorium & Hospital since 2019 and continued her aspiration in the implementation of innovative radiotherapy techniques and research works. She is dedicated in the set up and development of the Proton Therapy Service in the Hospital, the first in Hong Kong, the most cutting edge therapy that shows significant reduction of side effects of radiotherapy treatment compared to traditional X-ray based radiotherapy. She and the HKSH team developed a training program with Mayo Clinic Arizona, USA, with ongoing efforts aiming to train all related staffs for safe practice of the new technique. She is recognized as a council member in various international radiotherapy groups such as the steering committee member for the Proton Particle Therapy Co-operative group (PTCOG), international committee council member of the American Brachytherapy Society, European Brachytherapy Group (GEC-ESTRO), and locally, honorary teaching positions in both HKU, CUHK and HKU-Shenzhen Hospital, with continue academic collaborations with various universities including HK Polytechnique University. Amy Chang and Tae-hyun Kim Mini Oral Presentation 4B (Physics) Judges of Mini Oral Presentations: Dongho Shin and Toshiyuki Toshito
16:00 – 17:00	Session 8B (Clinical): Updates on Clinical Management Moderators: Wai-tong Ng and Ru-xin Wong
	Skull Base Jonathan Ashman Medical Director of Proton Therapy Program Associate Professor Department of Radiation Oncology Mayo Clinic USA Jonathan B. Ashman, M.D., Ph.D. is a radiation oncologist at Mayo Clinic in Phoenix, Arizona, USA. Dr. Ashman currently holds the rank of Associate Professor in the Mayo Clinic College of Medicine and Science. He serves as the Medical Director of the Mayo Clinic Arizona Proton Therapy program. Dr. Ashman received his medical and graduate degrees from the University of Chicago Pritzker School of Medicine. He completed radiation oncology residency at Memorial Sloan-Kettering Cancer Center in New York, New York, USA. Dr. Ashman's clinical specialties include treatment of CNS tumors (brain/base of skull/spine), sarcoma (extremity, retroperitoneal, chordoma/chondrosarcoma), and gastrointestinal malignancies (esophagus, stomach, pancreas, hepatobiliary, colorectal, anus). National positions include membership on the National Association for Proton Therapy (NAPT) Physician Advisory Committee and on the American Society for Radiation Oncology (ASTRO) Guidelines Committee. Dr. Ashman is an Associate Editor (Gastrointestinal Oncology section) for the International Journal of Radiation Oncology-Biology-Physics (IJROBP). Jonathan Ashman (USA)
	Particle Radiotherapy for Head and Neck Malignancies: A Decade of Clinical Experience at SPHIC Lin Kong Radiation Oncologist Fudan University Shanghai Cancer Center China Lin Kong (China)
17:00 – 18:00	Discussion Forum 2: Head and Neck Cancer Topics: Patients, Technique, Proton vs Carbon, Optimizing Systemic Therapy Moderators: Chun-key Law Co-director of Proton therapy Centre Honorary Consultant in Clinical Oncology Comprehensive Oncology Centre, Department of Medicine Hong Kong Sanatorium & Hospital Hong Kong Dr. CK Law graduated from University of Hong Kong in 1981 and joined the Department of Radiotherapy & Oncology (now called Department of Clinical Oncology), Queen Elizabeth Hospital in 1982. He had post-Fellowship training in United Kingdom, Japan and the USA. He became Chief of Service in 2003 until retirement from the public service in 2012. He had been the Director of Hong Kong Cancer Registry, Hospital Authority in 2004 - 2012 and President of Hong Kong College of Radiologists in 2008 - 2023. Dr. Law is currently a member of the Cancer Expert Working Group (CEWG) of the Centre for Health Protection (CHP) as well as the Advisory Committee for Regulatory Standards for Private Healthcare Facilities, Department of Health. He is also an Honorary Clinical Associate Professor in Department of Clinical Oncology, The University of Hong Kong, and Clinical Associate Professor (Honorary), Department of Medicine and Therapeutics, The Chinese University of Hong Kong. He is currently serving in Hong Kong Sanatorium and Hospital as Honorary Consultant in Clinical Oncology and Co-director of Proton Therapy Centre in HKSH Eastern Medical Centre. Chun-key Law and Yu-ming Wang Panelists: Martin Bues Lead Proton Physicist and Professor of Radiation Oncology Department of Radiation Oncology Mayo Clinic USA Martin Bues (USA), Jun-lin Yi Professor Cancer Hospital of Chinese Academy of Medical Sciences China Junlin Yi, MD, Chief Professor, Chairman, Dept. Radiation Oncology Cancer Hospital, Chinese Academy of Medical Sciences. Graduated from Hunan medical university in 1993, working in Cancer Hospital, Chinese Academy of Medical Sciences for more than 30 years, major in Head and neck cancer, especially in nasopharyngeal carcinoma. As first author or correspondent author, published more than 30 SCI paper in recently 5years, many of them are published in high level journal, such as "JAMA Oncology", "JAMA network open", "Clin Cancer Res", "Med Comm", "Front. Immunol", "J Transl Med", "JNCC", "Radiother Oncol", etc. Served as vice chairmen, Committee of Nasopharyngeal Carcinoma, Chinese Anti-Cancer Association (CACA), and President- elect, Expert Committee of Nasopharyngeal Carcinoma, Chinese Society of Clinical Oncology (CSCO). Jun-lin Yi (China), Lin Kong Radiation Oncologist Fudan University Shanghai Cancer Center China Lin Kong (China) and Brigette Ma Professor Department of Clinical Oncology The Chinese University of Hong Kong Hong Kong Dr Brigette Ma is currently Professor and Honorary Consultant at the Department of Clinical Oncology, Chinese University of Hong Kong (CUHK), Medical Director of the Phase I Clinical Trial Centre (Oncology) and Chair of the NTEC-CUHK ethics committee for phase 1 studies. She received her undergraduate degree with Honours at Monash University, Australia, and was awarded Fellow of the Royal Australasian College of Physicians, Fellow of Hong Kong College of Physicians, and Doctor of Medicine (CUHK). Dr Brigette Ma underwent training in Medical Oncology at the Peter MacCallum Cancer Institute, Melbourne, and was Research Fellow at the Princess Margaret Hospital, Toronto, Canada. She has published over 200 peer-reviewed papers. Notably, she had been a Faculty member of the European Society of Medical Oncology (ESMO) in Gastrointestinal Cancer, and was a member of the Consensus Working Group for the management of metastatic colorectal cancer; executive member of the National Cancer Institute (Bethesda, USA) Head and Neck Cancer Steering Committee - Clinical Trials Planning Group on Nasopharyngeal Cancer, Co-chair of Widely Metastatic Group; mentor and committee member of the Women in Cancer Research of the American Association of Cancer Research; and Scientific Co-chair of ESMO (Asia) conference 2023 in Singapore. Her other current roles included: member of the Joint Scientific Committee for Phase 1 Clinical Trials, Centre of Health Protection, Hong Kong Hospital Authority; Track Chair/ member of the Scientific Committee American Association of Cancer Research, ESMO congresses. She is study chair for NRG oncology clinical trial in NPC, Scientific Co-chair of the ESMO Targeted Anticancer Therapies Asia Congress 2025 and co-chairs for some ESMO advanced course/ workshops concerning early drug development. She is Associate Editor of Oral Oncology and is member of the Editorial Board for ESMO Open (GI) and Clinical Colorectal Cancer amongst other journals. Brigette Ma (Hong Kong, China)

10:30 – 12:10	Session 5C (Physics): Oral Presentation Moderators: Zuo-feng Li Professor Radiation Oncology UF Health Proton Therapy Institute University of Florida USA Dr. Zuofeng Li is a Professor of Radiation Oncology at University of Florida and works in the University of Florida Health Proton Therapy Institute (UFHPTI). Dr. Li previously served as the Chief Proton Therapy Physicist of Concord Medical Services and the Physics Director of Guangzhou Concord Cancer Center. His previous tenures also include serving as the Director of Physics at UFHPTI and faculty positions at Washington University in St. Louis and University of Florida. Dr. Li has over 30 years of experience in the art and science of clinical radiation oncology physics, with over 20 of which dedicated to proton therapy. Dr. Li is an author of over 170 peer-reviewed journal publications, with subject topics including radiotherapy treatment planning, dosimetry, quality assurance, and clinical outcome studies of proton therapy, photon external beam radiotherapy and brachytherapy. Dr. Li is a Fellow of the American Association of Physicists in Medicine. Zuo-feng Li and Kimi Yang Assistant Senior Medical Physicist Medical Physics Department, HKSH Eastern Medical Centre HKSH Proton Therapy Centre Hong Kong Dr. Kimi Yang serves as an Assistant Senior Medical Physicist at Hong Kong Sanatorium & Hospital, specializing in cutting-edge radiotherapy technologies such as MR-guided radiotherapy, proton therapy, and CyberKnife. With a Ph.D. in Physics from The University of Hong Kong and a B.Sc. from Nanjing University, Dr. Yang brings over a decade of expertise to the field, driving advancements in adaptive therapy, motion management, and dosimetry. A Certified Medical Physicist accredited by the Hong Kong Institution of Physicists in Medicine (HKIPM), he actively contributes to the community as Secretary of HKIPM, Education and Training Committee Member at AFOMP, and Scientific Committee Member of PTCOG-AO. As an Honorary Assistant Professor at HKU, Dr. Yang dedicates efforts to training and academic initiatives, fostering education across universities and professional institutions. His scholarly contributions are widely recognized, with publications in high-impact peer-reviewed journals and presentations at international forums. Kimi Yang Judges: Hong-qi Tan Deputy Head of Medical Physics Division of Radiation Oncology National Cancer Centre Singapore Tan Hong Qi is currently the deputy head of medical physics in joined National Cancer Centre Singapore (NCCS) overseeing clinical and research project. He holds an adjunct assistant professor position in Nanyang Technological University and developed the first medical physics bachelor program in Singapore. He is a diplomate of International Medical Physics Certification Board (IMPCB) and is also a clinical instructor in the Duke-NUS medical school as well. He has received multiple awards at the institutional, national and international level. This includes the SingHealth AHP young discoverer award in 2021, represented Singapore as an invited expert to IAEA technical meeting on radiation protection of paediatric and pregnant patients in 2023, SEAFOMP Young Leader award in 2023 and the IUPAP early career scientist award in 2023, innovative practice team awards in 2024 and 2025. Hong-qi Tan and Dayananda Sharma Professor and Head Department of Medical Physics Apollo Proton Cancer Centre India Dayananda Sharma
12:30 – 14:00	Lunch Break
14:00 – 15:40	Session 6C (Clinical / Biology): Oral Presentation Moderators: Daniel Chua and Warissara Rongthong Judges: Yu-Ming Wang and Ru-xin Wong
15:40 – 16:00	Coffee Break, Exhibition and e-Poster Viewing Mini Oral Presentations 4A (Clinical / Biology) Judges of Mini Oral Presentations: Amy Chang Co-director HKSH Proton Therapy Centre Hong Kong Sanatorium & Hospital Hong Kong Dr. Chang is currently Honorary Consultant in Clinical Oncology at Hong Kong Sanatorium & Hospital, co-director of HKSH Proton Therapy Centre, Honorary Clinical Associate Professor (CUHK) and Honorary Clinical Assistant Professor of the Department of Clinical Oncology, The University of Hong Kong. She obtained Bachelor of Science in Biological Chemistry at University of Chicago and obtained her medical degree from The University of Hong Kong in 2002. After internship she was trained in Department of Clinical Oncology of Pamela Youde Nethersole Eastern Hospital. She is a fellow of the Royal College of Radiologists and Hong Kong College of Radiologists (2012) and worked as Clinical Assistant Professor at University of Hong Kong Department of Clinical Oncology. During her service at the Hospital Authority and as an academic staff, she obtained the Hong Kong College of Radiologists Fellowship Grant to study advanced radiotherapy technique in Cambridge University, and was also trained at Medical University of Vienna. She pioneered in MR-guided brachytherapy for cervix cancer in her institute, organized training workshops, and also led a multi-center research study as the principal applicant of the Government Health and Medical Research Fund (HMRF) on the clinical outcome of this advanced technology for cervix cancer patients. She joined Hong Kong Sanatorium & Hospital since 2019 and continued her aspiration in the implementation of innovative radiotherapy techniques and research works. She is dedicated in the set up and development of the Proton Therapy Service in the Hospital, the first in Hong Kong, the most cutting edge therapy that shows significant reduction of side effects of radiotherapy treatment compared to traditional X-ray based radiotherapy. She and the HKSH team developed a training program with Mayo Clinic Arizona, USA, with ongoing efforts aiming to train all related staffs for safe practice of the new technique. She is recognized as a council member in various international radiotherapy groups such as the steering committee member for the Proton Particle Therapy Co-operative group (PTCOG), international committee council member of the American Brachytherapy Society, European Brachytherapy Group (GEC-ESTRO), and locally, honorary teaching positions in both HKU, CUHK and HKU-Shenzhen Hospital, with continue academic collaborations with various universities including HK Polytechnique University. Amy Chang and Tae-hyun Kim Mini Oral Presentation 4B (Physics) Judges of Mini Oral Presentations: Dongho Shin and Toshiyuki Toshito
16:00 – 18:00	Session 7C: PTCOG-AO New Centres and Developments Moderators: Tatsuya Ohno Chair and Director Department of Radiation Oncology Gunma University Heavy Ion Medical Center Japan Dr. Ohno is a radiation oncologist, Professor and Chair of Department of Radiation Oncology of Gunma University, and Director of Gunma University Heavy Ion Medical Center, Japan. He is also Chair of the Asia-Oceania Particle Therapy Cooperative Group (PTCOG-AO). He is a core member of the particle therapy community in Japan, and active member of the Japan Carbon-ion Radiation Oncology Study Group (J-CROS). He has served as a Course Director on International Training Course on Carbon-ion Radiotherapy (ITCCIR) co-hosted by QST hospital and Gunma University since 2012. He has published more than 250 papers on clinical and basic research and has collaborated many overseas particle therapy projects. Tatsuya Ohno and Darren Ming-chun Poon
	Particle Therapy in Asia and Oceania: Status and Sustainability – Results from the 2025 PTCOG-AO Survey Chan-kyu Kim Medical Physicist Proton Therapy Center (& Dept. of Radiation Oncology) National Cancer Center Korea Chankyu Kim, PhD, has been working as a Medical Physicist at the Proton Therapy Center and the Department of Radiation Oncology of the National Cancer Center Korea since 2017. His work focuses on clinical quality assurance, beam modeling, and the development of advanced detector technologies for proton therapy. Dr. Kim is a member of the Scientific Committee of the Asia-Oceania Particle Therapy Cooperative Group (PTCOG-AO), actively contributing to academic initiatives and collaborative research in the region. At this meeting, he will present the results of the PTCOG-AO survey on particle therapy, which provides important insights into clinical practice patterns and regional developments. Chan-kyu Kim (Korea)
	Generating Quality Data for Particle Beam Therapy from the AO Region – Opportunities and the Way Forward Rakesh Jalali Medical Director Apollo Proton Cancer Centre India Prof. Rakesh Jalali is a leading global expert in particle therapy and the Medical Director of the Apollo Proton Cancer Centre (APCC), India's first and South Asia's most advanced proton therapy facility. He played a pivotal role in establishing the clinical and academic framework of APCC, and spearheaded the Apollo-IBA Proton Training Academy to build capacity in proton therapy across the region. He has been an invited expert at the World Forum on Particle Therapy and at the International Atomic Energy Agency (IAEA) headquarters in Vienna, contributing to global guidelines on proton facility implementation in low- and middle-income countries. With over 300 peer-reviewed publications in leading journals including Lancet Oncology, JAMA Oncology, and Neuro-Oncology, Prof. Jalali has led several pioneering studies in high-precision radiotherapy, proton therapy planning and delivery, and radiation-induced toxicities. He is also an active mentor and educator, deeply involved in global academic collaborations and training initiatives. A strong advocate for equitable cancer care, he has led patient-focused initiatives and contributed to shaping proton therapy practice globally. Rakesh Jalali (India)
	Update on the Upcoming Research / New Facilities for Australian Center Michael Penniment Director Radiation Oncologist Australian Bragg Center, Adelaide Australia Michael Penniment (Australia)
	Update on the Upcoming Research / New Facilities for Zhejiang Cancer Hospital Ji Zhu Vice President and Director of the Heavy Ion Medical Center Zhejiang Cancer Hospital Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) China Dr. Ji Zhu is Vice President of Zhejiang Cancer Hospital, Director of the Ethics Committee, Director of the Heavy Ion Medicine Center, and Deputy Director of the Colorectal Cancer Quality Control Expert Committee of the National Cancer Center/National Cancer Quality Control Center. Title: Chief Physician, Doctoral Supervisor. His main research directions are the sensitivity of radiotherapy for abdominal tumors, the prediction of therapeutic effects and the prevention of adverse reactions, individualized and precise treatment, the prediction of radioactive adverse reactions by artificial intelligence models, and the establishment of individualized chemoradiotherapy strategies for rectal cancer through multi-omics and heavy ion technology. He has won numerous national and provincial-level awards in the field of abdominal tumor radiotherapy and is a nationally renowned expert in this area, with rich clinical experience and cutting-edge research ideas. Ji Zhu (China)
	Introduction of Proton Center of Guangzhou Concord Cancer Center (GCCC) Michael Tai-ze Yuan Director Radiation Oncology Guangzhou Concord Cancer Center China Dr. Taize Yuan, M.D., Chief physician, Director of RadOnc Dept and Proton Center of GCCC. Member of the second Youth Council of China Anti-Cancer Association Chairman of Radiotherapy Committee, Guangdong Organ Medicine and Technology Society Deputy Director of Oncology Medical Management Branch, Guangdong Medical Association Standing member of Tumor Microenvironment Committee , Chinese Anti-Cancer Association Standing member of Ion Radiotherapy Branch, Chinese Medical Equipment Association 2015.7-2016.7 visiting scholar at the Proton Center of the University of Florida and Cancer Center of the University of Iowa 2019.11-2020.5 6 Training on Proton therapy in Mayo Clinic Michael Tai-ze Yuan (China)
	Current Status and Future Perspectives of Proton Therapy at Central Japan Medical Center Shigeru Yamada General Manager Proton Therapy Center/Central Japan International Medical Center Medical Advisor/QST Hospital Japan Dr. Shigeru Yamada specializes in particle therapy for gastrointestinal cancers, particularly pancreatic and colorectal cancer. He received his M.D. from Mie University in 1985 and Ph.D. from Chiba University in 1995. After working in surgery at Chiba University and serving as Chief of Gastroenterological Surgery at Chiba Cancer Center Hospital, he completed postdoctoral research in Radiation Biophysics at NASA's Johnson Space Center in Houston, USA. He then joined the National Institute of Radiological Sciences (NIRS), advancing research in radiation oncology and charged particle therapy. At the National Institutes for Quantum Science and Technology (QST), he served as Director of the Department of Charged Particle Therapy Research, Deputy Director, and Director of QST Hospital. Since 2025, he has been Head of the Proton Therapy Center at the Central Japan International Medical Center and Medical Advisor at QST Hospital, and he has served as Visiting Professor at Chiba University since 2011. Shigeru Yamada (Japan)
	Recent Progress at the Heavy Ion Therapy Center, Yonsei University College of Medicine Ik-jae Lee Professor Department of Radiation Oncology Yonsei University College of Medicine Korea Professor Ik Jae Lee is a distinguished radiation oncologist at Yonsei University College of Medicine and currently serves as the Vice Director for Innovation Affairs at Severance Hospital. He is also the Director of the Pancreatobiliary Cancer Center at Yonsei Cancer Center, where he leads a multidisciplinary effort to improve outcomes for patients with pancreatic and biliary tract cancers. He previously led the Heavy Ion Therapy Center, where he played a pivotal role in introducing carbon ion radiotherapy in Korea. His clinical and research interests focus on prostate and gastrointestinal cancers—particularly liver and pancreatic cancer—and the application of advanced radiotherapy techniques, including carbon ion therapy. As the Director of International Affairs for the Korean Society for Radiation Oncology (KOSRO), Professor Lee plays a key role in fostering global partnerships. Ik-jae Lee (Korea)